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Abstract
Background: Several studies in animal models suggest a possible effect of the specific part of the Y-chromosome (Y
NPAR)o n
brain opioid, and more specifically on brain b-endorphin (BE). In humans, male prevalence is found in autistic disorder in
which observation of abnormal peripheral or central BE levels are also reported. This suggests gender differences in BE
associated with genetic factors and more precisely with Y
NPAR.
Methodology/Principal Findings: Brain BE levels and plasma testosterone concentrations were measured in two highly
inbred strains of mice, NZB/BlNJ (N) and CBA/HGnc (H), and their consomic strains for the Y
NPAR. An indirect effect of the
Y
NPAR on brain BE level via plasma testosterone was also tested by studying the correlation between brain BE concentration
and plasma testosterone concentration in eleven highly inbred strains. There was a significant and major effect (P,0.0001)
of the Y
NPAR in interaction with the genetic background on brain BE levels. Effect size calculated using Cohen’s procedure
was large (56% of the total variance). The variations of BE levels were not correlated with plasma testosterone which was
also dependent of the Y
NPAR.
Conclusions/Significance: The contribution of Y
NPAR on brain BE concentration in interaction with the genetic background
is the first demonstration of Y-chromosome mediated control of brain opioid. Given that none of the genes encompassed
by the Y
NPAR encodes for BE or its precursor, our results suggest a contribution of the sex-determining region (Sry, carried by
Y
NPAR) to brain BE concentration. Indeed, the transcription of the Melanocortin 2 receptor gene (Mc2R gene, identified as the
proopiomelanocortin receptor gene) depends on the presence of Sry and BE is derived directly from proopiomelanocortin.
The results shed light on the sex dependent differences in brain functioning and the role of Sry in the BE system might be
related to the higher frequency of autistic disorder in males.
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Introduction
The Y chromosome includes the Y
NPAR and the Y
PAR. The Y
NPAR
is called non-pairing or specific region and is transmitted from
father to sons exclusively. The Y
PAR recombines with the X
chromosome at the male meiosis and is called pairing or
pseudoautosomal region for this reason. Few functional genes
are mapped on Y
NPAR (histocompatibility Y antigen, RNA binding
motif protein, and several other genes contributing to male
reproduction such as Sry and genes necessary for the spermatozoon
development and maintenance). Several lines of evidence suggest a
possible effect of Y
NPAR on brain opioid, and more specifically on
brain b-endorphin (BE). Neonatal injection of testosterone
decreases brain BE concentration and the number of m receptors
in the hypothalamus (m receptors are receptors of BE) [1,2]. In
addition, neonatal injection or exposure to testosterone contributes
to the ‘‘male pattern’’ of the ontogenesis of m receptors in the
hypothalamus and to the development of BE innervations in the
brain [2–6]. Inversely, intracerebro-ventriculaire injection of BE
decreases plasma Luteinizing Hormone concentration and conse-
quently plasma testosterone concentration; this effect involves the
m receptors and is blocked by the preliminary administration of
Naloxone (an antagonist of the m receptors) [7–10]. Given these
previous observations and because Y
NPAR is involved in plasma
testosterone concentration and testicular reactivity to testosterone
[11,12], the Y
NPAR is expected to be associated with brain BE.
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  data  collection  and  analysis,  decision  to  publish,  or  preparation  of This hypothesis of an effect of the Y
NPAR on brain BE is also
supported by studies in mice models and in humans showing an
inhibitory influence of central opioids acting through the m
receptors (such as BE) on aggressive behavior [13–20], and an
effect of the murine Y
NPAR on aggression [21–25]. In addition,
Laarakker et al.’s study [26] reporting a contribution of the Y
NPAR
to anxiety-related behavior in mice, strengthens the hypothesis of
an effect of the Y
NPAR or brain BE, given that BE is considered as a
stress hormone [27–29].
Finally, in humans, and more precisely in autistic disorder, two
other arguments support our hypothesis: on one hand, the fourfold
higher prevalence of autism in male compared to female [30]
(autism is a pervasive developmental disorder for which family and
twin studies suggest a genetic contribution [31–33]) could indicate
a contribution of the Y
NPAR; on the other hand, several studies
have reported abnormal central as well as peripheral BE levels in
individuals with autism [34].
The present study was designed first to test directly the effect of
Y
NPAR on brain BE levels in two highly inbred strains of mice,
NZB/BlNJ (N) and CBA/HGnc (H), and their consomic strains
for the Y
NPAR. Second, an indirect effect of the Y
NPAR on brain BE
level via plasma testosterone was tested by studying the genetic
correlation between brain BE concentration and plasma testos-
terone concentration in eleven highly inbred strains of mice.
Methods
Mice and rearing conditions
Brain b-endorphin and plasma testosterone were measured in a
set of inbred strains of mice and in a quartet of parental and their
consomic strains for the Y
NPAR. The set of inbred strains consisted
in 11 inbred mouse strains A/J, XLII, BA, BALB/cBy, C57BL/
10Bg, C57BL/6Jby, CPB-K, DBA/1Bg, DBA/2j, CBA/HGnc
and NZB/BlNJ. The strains were maintained in the laboratory for
six or more generations of brother-sister mating regimen. The
quartet of parental and their consomic strains for the Y
NPAR was
developed as follows: we selected two strains of laboratory mice
NZB/BlNJ (N) and CBA/HGnc (H) that were known for the
different origin of their respective Y chromosomes. Furthermore,
N and H were selected because the N males, who present the
highest scores for aggression and the highest plasma testosterone
concentration compared to the H males [1,3,7–10,13–20], were
expected to have also lower brain BE levels as suggested by
previous reports described in the introduction [13,35]. The
production of the consomics for the Y
NPAR has been previously
described [12,36]. The HNF1 males carried the N-Y
NPAR of the N
donor strain because the Y
NPAR is paternally transmitted. The
males were sired with an H female. The progeny carried the N-
Y
NPAR but 50% of the N genes were lost and replaced by H genes
at each generation. The N-Y
NPAR was substituted to the H-Y
NPAR
after several generations of repeated backcrosses. The H strain and
its consomic H.N-Y
NPAR differed only by the origin of N-Y
NPAR
that is H-Y
NPAR in the parental and N-Y
NPAR in the consomics. A
similar strategy was developed to develop the consomic N.H-
Y
NPAR, with the N strain as recipient and H as donor strain for the
Y
NPAR. The males came from the 25 and 26
th backcross
generations when they were used for the present experiments.
The probability to have one allele from the autosomes, X
chromosome and Y
PAR from the donor strain in the consomic is
below 5610
28 under these conditions. In addition, with
homozygous autosomal alleles no genomic imprinting could
contribute to the difference between a parental and its congenic
strain. The isogenicity between each parental and its consomic
strain was confirmed by the acceptance of reciprocal skin grafts
and identity of mandible shape measurements [37,38] because
both are controlled by a large number of loci spread on the
genome [39]. This isogenicity between each parental and the
respective consomic strain was also tested by comparing 123 Mit
polymorphisms (unpublished). Moreover, each parental strain and
its consomic had identical genetic information for the Sts locus
mapped on the Y
PAR [36].
Four to six littermates were housed with their mother in a
42611618 cm plastic cage and a bedding of dust-free sawdust
with food and water ad libitum, temperature 24.060.5uC and
lights on at 08:00 AM. Weaning took place at 2862 days of age.
Males were then placed with the same age female (usually a
littermate) and were killed at 6664 days by cervical dislocation.
Cervical dislocation was selected as being the more rapid
technique for euthanasia. The whole brains (after removing
olfactory bulbs and cerebellum) were saved for biochemical
analyses and stored at 280uC. The blood was collected by intra-
cardiac puncture in 10 ml of heparin and the plasma was kept at
225uC. The experimental protocol with the mice was conducted
according to the European guidelines and was approved by the
National Committee of the Scientific Research (CNRS).
Biochemical analyses
Brain tissues were homogenized in 5 volumes of 0.1 M HCl and
heated for 15 min at 95uC. After centrifugation (38,0006g,
10 min, 4uC), the supernatant was adjusted to pH 7.0 with 1 M
Tris base, and the resulting precipitate was spun down at 6,0006g
for 10 min at 4uC. Protein concentrations were determined in the
pellets by the method of Lowry et al. [40] with bovine serum
albumin as the standard. Brain BE levels are expressed in
picomoles per gram of fresh tissue.
The plasma testosterone was assayed according to RIA in
coated tubes using a specific testosterone antibody exhibiting a
reduced cross-reaction (7.5%) with other androgen steroids (
125 I-
TESTOSTERONE COATRIA, kit Biome ´rieux). The competi-
tive inhibition reaction was measured between a fixed amount of
125 I-labelled testosterone and the testosterone to be determined
(standards or samples) for a fixed number of binding sites on the
anti-testosterone antibody. Coated tubes, containing plasma and
125 I-testosterone tracer, were incubated for 2 h at 37uC. The
125 I-testosterone bound was separated from that remaining in
solution. The bound radioactivity counted for 1 min was then
inversely proportional to the testosterone quantity in standards or
samples. Each individual sample was assayed in duplicate and the
sample again assayed when the difference between the two results
was over 20%.
Statistical analyses
The effect of the Y
NPAR on brain BE level and plasma testosterone
concentration was studied using a two-way ANOVA, with genetic
background -H versus N- and origin of the Y
NPAR -H versus N- as
main factors. Effect size was calculated using the h
2 statistic and
expressed as a percentage of variance [41]. Comparisons between the
11 inbred mouse strains for BE or testosterone variables were
performed using ANOVA. The Kolmogorov-Smirnov test indicated
that BE and testosterone levels were not normally distributed; thus all
ANOVAs were performed using log-transformed BE and testosterone
values. Correlations between brain BE levels and plasma testosterone
concentrations in the 11 inbred mouse strains (each strain is
represented by the mean of five animals for biological variables) were
determined by Spearman rank-order correlation analyses. According
to Hegmann and Possidente [42], these correlations between
b i o l o g i c a lm e a s u r e sc a nb ec o n s i d e r e da sa ne s t i m a t i o no fg e n e t i c
correlations. The significance level was set at 0.05; however, the usual
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on mean scores and not on individual scores.
Results
Effect of the Y
NPAR on brain b-endorphin levels
Brain BE levels were significantly modified by the non-Y
NPAR
genotype and the Y
NPAR in interaction with non- Y
NPAR genotype
(F(1,17)=4.80, P,0.04, h
2=0.10 and F(1,17)=27.18, P,0.0001,
h
2=0.56, respectively). The Y
NPAR alone did not contribute
significantly to BE concentration (F(1,17),1). Partial comparisons
indicated that BE levels were significantly higher in the H strain
than in the N strain (t (1.47)=2.43, P,0.05). The substitution of
the Y
NPAR from H by the Y
NPAR from N, in the H strain, reduced
significantly the brain BE concentration, and the substitution of
the Y
NPAR from N by the Y
NPAR from H, in the N strain, reduced
the brain BE level to the lowest concentration.(see Figure 1).
Effect of the Y
NPAR on plasma testosterone concentration
The non-Y
NPAR genotype, the Y
NPAR region and their interactions
modulated significantly plasma testosterone concentration (F
(1,17)=48.42, P,0.0001, h
2=18.20; F(1,17)=109.15, P,0.0001,
h
2=0.41 and F(1,17)=72.63, P,.0001, h
2=27.28, respectively).
Partial comparisons indicated that testosterone concentration were
significantly higher in the N strain than in the H strain (t
(5.99)=11.97, P,0.0001). The substitution of the Y
NPAR from N by
theY
NPARfromH,inthe N strain, reducesignificantlythe testosterone
concentration (t (5.99)=13.37, P,0.001), whereas the opposite
replacement of the Y
NPAR from H by the Y
NPAR from N, in the H
strain, did not modify the testosterone concentration (see Figure 2).
Figure 1. Brain BE concentration (mean ±SEM) in NZB and CBA/H and their consomic strains for Y
NPAR. The N.H-Y
NPAR differs only from
the NZB by the Y
NPAR from CBA/H, and the H.N- Y
NPAR differs only from the CBA/H by the Y
NPAR from NZB. Partial comparisons with Student’s t test
showed that the parental NZB and CBA/H strains differed significantly (P,0.05), and each parental strain differed significantly from its consomic strain
(CBA/H vs.H.N-Y
NPAR: P,0.001; NZB vs. N.H-Y
NPAR: P,0.01); n=5 animals for each strain, except for NZB (n=6); SEM=standard error of the mean.
doi:10.1371/journal.pone.0016704.g001
Figure 2. Plasma testosterone concentration (mean ±SEM) in NZB and CBA/H and their consomic strains for Y
NPAR. The N.H-Y
NPAR
differs only from the NZB by the Y
NPAR from CBA/H, and the H.N-Y
NPAR differs only from the CBA/H by the Y
NPAR from NZB. Partial comparisons with
Student’s t test showed that the parental NZB and CBA/H strains differed significantly (P,0.0001), and the parental NZB strain differed significantly
from its consomic strain (NZB vs. N.H-Y
NPAR: P,0.001); n=10 animals for each strain; SEM=standard error of the mean.
doi:10.1371/journal.pone.0016704.g002
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The data of brain BE levels and plasma testosterone
concentrations (mean 6 SEM) in the 11 inbred strains are
presented in Table 1. The 11 inbred mouse strains did not differ
significantly for BE or testosterone concentrations. In addition,
there was no correlation between brain BE levels and plasma
testosterone concentration when the analysis was conducted on the
eleven different inbred strains including the same N and H males
contributing to the present study (r spearman=0.09, P.0.1).
Discussion
Our main data indicated a significant and major effect of the
Y
NPAR in interaction with the genetic background on brain BE
levels. The controls to ensure the isogenicity of the background in
each parental strain and its consomic strain rule out a possible
contribution of residual autosomal alleles from the donor strain to
this effect of the Y
NPAR in interaction with the genetic background.
None of the annotations of the genes carried by the Y
NPAR allows
us to consider that one of them contributes directly in the BE
production [43].
An indirect effect of the Y
NPAR in interaction with the genetic
background on brain BE levels via plasma testosterone is not
supported by our findings. Indeed, there was no correlation in this
study between brain BE levels and plasma testosterone concen-
trations, although this research is limited by the absence of
variability of BE or testosterone concentration between the 11
inbred strains. In addition, our results on plasma testosterone
measured in the parental N and H and their consomic strains
confirm our previous study [12] and indicate that the strain
distribution pattern differs for brain BE levels and plasma
testosterone concentrations; the Y
NPAR from N, which depleted
BE on the H background, had no effect on testosterone. Thus, the
strong decremental effect on brain BE levels resulting from the
transfer of the Y
NPAR from N on H, cannot be explained by
variations of plasma testosterone concentrations. Furthermore, the
statistical effects of the Y
NPAR substitution are not the same in BE
and testosterone: first, the Y
NPAR modulates BE concentration via
an interactive effect with the genetic background and with no
significant effect of Y
NPAR alone, whereas testosterone concentra-
tion is modulated by the Y
NPAR substitution alone and by an
interaction between the Y
NPAR and the genetic background.
Finally, effect size of the non-Y
NPAR genotype, the Y
NPAR and
their interactions differ for BE and testosterone.
The indirect effect of the Y
NPAR in interaction with the genetic
background on brain BE levels might be explained by a
contribution of the sex-determining region of the Y chromosome
(Sry) carried by Y
NPAR [44–47]. Thus, the transcription of the
Melanocortin receptor (Mc2R) gene depends on the presence of Sry
[45,48]. Mc2R gene, located on chromosome 18, has been
identified as the gene of the receptor of proopiomelanocortin.
Proopiomelanocortin plays an important role in the BE system
given that BE is directly derived from proopiomelanocortin. The
Y
NPAR has different origins in inbred strains of mice. The N and H
strains are from Asian and European origins, respectively. An
analysis of the Y
NPAR patterns of restriction reveals that the N and
H strains belong to different groups [49] suggesting Sry
polymorphisms. We hypothesized that Sry polymorphisms between
Y
NPAR from N and Y
NPAR from H, modify the transcription of
several genes including Mc2R, resulting in the modification of BE
brain concentration.
The effect of the Y
NPAR on brain BE concentration in interaction
with the genetic background reported in the present study is the
first demonstration of Y-chromosome mediated control of brain
opioid. The results open new perspectives to better understand sex
differences observed in some disorders such as autistic disorder,
where abnormal central BE levels have been reported. Finally, the
findings could have important implications for research on the
genetic control of BE metabolic pathways.
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